	Democrats press Pfizer, J'J and others over low tax bills and lobbying as Senate debates Trump's plan - CNBC
	J'J survey finds pace of oncology innovation is overwhelming physicians - Fierce Pharma
	J'J ties early-stage lymphoma CAR-T to 100% response rate in 10 patients - Fierce Biotech
	J'J boosts US manufacturing as big pharma reshores - BioPharma Dive
	J'J CEO Duato Urges Tax Fix, Not Tariffs To Drive US Pharma Manufacturing - BioSpace
	J'J CEO warns against pharmaceutical tariffs - Healthcare Brew
	J'J Ups U.S. Investment to More Than $55B - Contract Pharma
	America’s Johnson ' Johnson Problem - The Atlantic